Incidence of self-induced abortion with misoprostol, admitted to a provincial hospital in Papua New Guinea: A prospective observational study.
abortion law
misoprostol
self-induced-abortions
unintended pregnancy
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
08
07
2021
received:
25
03
2021
accepted:
10
07
2021
pubmed:
6
8
2021
medline:
15
12
2021
entrez:
5
8
2021
Statut:
ppublish
Résumé
Misoprostol is a life-savingmedication in obstetric practice but the prevalence of misoprostol-related self-induced abortion is increasing in many communities. To investigate the hospital incidence, clinical management, and legal framework of self-induced abortions with misoprostol. This was a prospective observational study conducted over 18 months. All patients <20 weeks pregnant who were admitted with a diagnosis of misoprostol-induced abortion were included in the study. Of 186 women with abortion-related admissions during the study period, 51 (27.4%) women reported using misoprostol to induce abortion. The majority were young (27.8 ± 5.5) married women (32/51: 62.7%), particularly educated (27/51: 52.9%) employed women (27/51: 52.9%), who were not on any contraception (46/51: 90.1%). Most abortions were induced in the first trimester (39/51: 76.5%) and patients were admitted because of prolonged bleeding (23/51: 45.1%). A significant proportion of participants who did not receive the correct dose of misoprostol developed sepsis compared to those who received a correct dose (6/18 (33.3%) vs 1/30 (3.3%); P = 0.008). The use of misoprostol as an abortifacient is increasing in Papua New Guinea, particularly among educated and employed women. A review of the laws to meet the demand for abortion services and to limit complications of unsafe abortion practices is required.
Sections du résumé
BACKGROUND
Misoprostol is a life-savingmedication in obstetric practice but the prevalence of misoprostol-related self-induced abortion is increasing in many communities.
AIMS
To investigate the hospital incidence, clinical management, and legal framework of self-induced abortions with misoprostol.
MATERIALS AND METHODS
This was a prospective observational study conducted over 18 months. All patients <20 weeks pregnant who were admitted with a diagnosis of misoprostol-induced abortion were included in the study.
RESULTS
Of 186 women with abortion-related admissions during the study period, 51 (27.4%) women reported using misoprostol to induce abortion. The majority were young (27.8 ± 5.5) married women (32/51: 62.7%), particularly educated (27/51: 52.9%) employed women (27/51: 52.9%), who were not on any contraception (46/51: 90.1%). Most abortions were induced in the first trimester (39/51: 76.5%) and patients were admitted because of prolonged bleeding (23/51: 45.1%). A significant proportion of participants who did not receive the correct dose of misoprostol developed sepsis compared to those who received a correct dose (6/18 (33.3%) vs 1/30 (3.3%); P = 0.008).
CONCLUSION
The use of misoprostol as an abortifacient is increasing in Papua New Guinea, particularly among educated and employed women. A review of the laws to meet the demand for abortion services and to limit complications of unsafe abortion practices is required.
Substances chimiques
Abortifacient Agents, Nonsteroidal
0
Misoprostol
0E43V0BB57
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
955-960Informations de copyright
© 2021 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 980-1004.
National Statistical Office (NSO) PNG. Papua New Guinea Demographic and Health Survey 2016-18. 2019.
Sanga K, de COSTA C, Mola G. A review of maternal deaths at Goroka general hospital, Papua New Guinea 2005-2008. Aust NZ J Obstet Gynacol 2010; 50: 21-24.
NDoH-NHIS. National Health Information Systems. Papua New Guinea: National Department of Health, 2009.
PNG Go. Criminal Code Act 1974pp.;Ordinance No.7 of 1902.revised 1974:Chapter 1262, parts 25, 26,80.
Vallely LM, Homiehombo P, Kelly-Hanku A, Whittaker A. Unsafe abortion requiring hospital admission in the Eastern Highlands of Papua New Guinea - a descriptive study of women’s and health care workers’ experiences. Reprod Health 2015; 12: 9-11.
Vallely LM, Homiehombo P, Kelly-Hanku A et al. Hospital Admission following Induced Abortion in Eastern Highlands Province, Papua New Guinea - a descriptive study. PLoS One 2014; 9: e110791.
Asa I, de Costa C, Mola G. A prospective survey of cases of complications of induced abortion presenting to Goroka Hospital, Papua New Guinea, 2011. Aust NZ J Obstet Gynaecol. 2012; 52: 491-493.
Hanschmidt F, Linde K, Hilbert A et al. Abortion stigma: a systematic review. Perspect Sex Reprod Health 2016; 48: 169-177.
Frohwirth L, Coleman M. Managing religion and morality within the abortion experience: qualitative interviews with women obtaining abortions in the U.S. World Med Health Policy 2018; 10: 381-400.
Prata N, Weidert K. Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning. Int J Womens Health 2016; 8: 341-349.
Yount SM, Lassiter N. The pharmacology of prostaglandins for induction of labor. J Midwifery Women Health 2013; 58(2): 133-144; quiz 238-9.
Bolnga J. Modilon Hospital Annual O&G Report. Madang: Modilon General Hospital, 2017.
Bolnga JW, Hamura NN, Umbers AJ et al. Insights into maternal mortality in Madang Province, Papua New Guinea. Int J Gynaecol Obstet 2014; 124: 123-127.
Mola G. O&G Standard treatment guidelines manual. 2016; 8.
https://www.figo.org/news/misoprostol-dosage-chart-new-release-0015613. 2017.
Faundes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynaecol Obstet 2007; 99(Suppl 2): S172-S177.
Harper CC, Blanchard K, Grossman D et al. Reducing maternal mortality due to elective abortion: potential impact of misoprostol in low-resource settings. Int J Gynaecol Obstet 2007; 98: 66-69.
Raymond EG, Harrison MS, Weaver MA. Efficacy of misoprostol alone for first-trimester medical abortion: a systematic review. Obstet. Gynecol. 2019; 133: 137-147.
Basu JKBD. The management of failed second-trimester abortion. Contraception 2009; 80(2): 170-173.
WHO, UNICEF U, World Bank Group and the United Nations Division. Trends in maternal mortality 1990 to 2015: estimates. Geneva, 2015.
Singh S, Maddow-Zimet I. Facility-based treatment for medical complications resulting from unsafe pregnancy termination in the developing world, 2012: a review of evidence from 26 countries. BJOG: Int J Obstet Gynaecol 2016; 123(9): 1489-1498. https://doi.org/10.1111/1471-0528.13552
Bankole A, Adewole IF, Hussain R, et al. The incidence of abortion in Nigeria. Int Perspect Sex Reprod Health 2015; 41: 170-181.
Ganatra B, Gerdts C, Rossier C et al. Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model. Lancet 2017; 390: 2372-2381.
Singh S, Shekhar C, Acharya R et al. The incidence of abortion and unintended pregnancy in India, 2015. Lancet Glob Health 2018; 6: e111-e120.
Winikoff B, Sheldon W. Use of medicines changing the face of abortion. Int Perspect Sex Reprod Health 2012; 38: 164-166.
Bolnga JW, Morris M, Totona C, Laman M. Maternal near-misses at a provincial hospital in Papua New Guinea: a prospective observational study. Aust NZ J Obstet Gynaecol 2017; 57: 624-629.
Bolnga JWMM, Aipit J, Laman M. Trends in maternal and perinatal mortality in a provincial Hospital in Papua new Guinea: a 6-year review. PNG Med J 2015; 59: 1-4.